Why the drop? | ANSV Message Board Posts

Anesiva, Inc.

  ANSV website
  • Membership Drive Update: In the first 48 hours we've hit almost 20% of our goal. An encouraging start to be sure, but we can't stop now. We need to pull enough subscription revenue forward to counter severe cash flow deficits resulting from a dramatic slow-down in ad spend thanks to the global pandemic which shows no signs of letting up in the near-term. We're doing everything in our power to keep our heads above some very choppy water, but we can't do it alone. We need your help. So if you've ever thought about giving our premium service a try, there's no better time to do it than right now by taking advantage of one of our discounted multi-year plans. Thanks in advance for your continued loyalty & support! 

  • Limited Premium Membership Offer
    Choose a Plan, Save Money & Help Us Survive the Pandemic

    Lifetime @ $399 (only 24 left)  5-yrs @ $199 (only 31 left)  2-yrs @ $99 (only 29 left)

ANSV   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  42 of 47  at  12/6/2007 4:53:54 PM  by


 In response to msg 41 by  
view thread

Re: Why the drop?

Maybe the cost of Zingo compared to the lidocaine creams currently being used. I've been a nurse for too many years to admit and have stuck countless patients with needles of all gages. The cream used most commonly at my hospital is EMLA. It's a lidocaine/procaine local anesthetic. Our pharmacy cost is about 8 bucks. If Zingo comes out at close to double that, then there will be a problem. Being a nurse I would vote to use it simply because of the time saving property it has. It's a real pain in the butt to plaster some cream on the site,cover it with a patch and wait 20-30 min. Also I would scream loud and clear that saving all that time is money. But, I've been on some pharmacy and therapeutic meetings discussing yes or no on what goes in the formulary and believe me the cost of the product speaks for its self. Every director in every department is looking at the here and now and how they can cut costs. The sales team will have it's work cut out for them. At this time I don't think Anesiva will make much off Zingo for some time. I agree with a recent post that Adlea will be the product to watch. It will be a godsend to post op ortho patients and to the nurses caring for them. I think of the big hit the opiate market will take. Will be nice. Just my simple take on this issue. Have a great day.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 634
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
43 Re: Why the drop? bubbaray 0 12/7/2007 10:13:38 AM

Financial Market Data provided by